Skip to the page content
Your donations
Passes our checks

Collaborative Group of the Americas on Inherited Gastrointestinal Canc

EIN 90-0843053 · Columbus, OH

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong100 out of 100GovernanceGood75 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE MISSION OF THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS TO OFFER: -EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS, ALLIED HEALTHCARE PROFESSIONALS, PATIENTS, AND THEIR FAMILIES. -ACCESS TO COLLABORATIVE TRIALS AND STUDIES. -RESOURCES FOR DEVELOPING NEW HEREDITARY REGISTRIES AND SUPPORTING THEIR REGISTRIES. -A FORUM FOR EXCHANGE OF IDEAS. -MULTIDISCIPLINARY EXPERTISE IN CLINICAL CARE, HEALTHCARE POLICY, AND RESEARCH RELATED TO HEREDITARY GASTROINTESTINAL CANCER.

Income
$311,413
Spending
$132,254
Spent on programs
100%
Reserves
71.9 months of spending
Largest source of income
fees for its services, 62%
Employees
0
Volunteers
81

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 100 out of 100. Higher than 81% of charities in its peer group (diseases, $250k to $1m).

  • Reserves

    35 of 35

    Spendable reserves would cover 71.9 months of spending.

  • Debt

    20 of 20

    It owes 2% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 58% of income.

  • Income trend

    15 of 15

    Income rose 68% on the year before.

  • Spending floor

    15 of 15

    100% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 75 out of 100. Higher than 46% of charities in its peer group (diseases, $250k to $1m).

  • Independent board

    25 of 25

    11 of 11 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $132,254 spent. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS DEVOTED TO THE PURSUIT OF PROVIDING CUTTING EDGE EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS AND ALLIED HEALTH CARE PROFESSIONALS. THIS IS ACHIEVED PRIMARILY THROUGH CONTINUING MEDICAL EDUCATION AND BY PROVIDING A FORUM FOR THE EXCHANGE OF IDEAS AT THE ANNUAL MEETING. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER AIMS TO ENCOURAGE PROFESSIONAL GROWTH, SIMULATE INTELLECTUAL CURIOSITY, AND IMPROVE PATIENT OUTCOMES BY EXPANDING ACCESS TO UP-TO-DATE INFORMATION OF INTEREST TO PRACTITIONERS AND RESEARCHERS. THE ANNUAL MEETING IS DESIGNED TO KEEP CLINICIANS AND SCIENTISTS UP-TO-DATE ON NEW DEVELOPMENTS IN HEREDITARY GASTROINTESTINAL CANCER RESEARCH, INCLUDING IMPLICATIONS IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PATIENTS WITH THE HEREDITARY GASTROINTESTINAL CANCER SYNDROMES. THE PROGRAM IS DIRECTED TO COLORECTAL SURGEONS, MEDICAL ONCOLOGISTS, GASTROENTEROLOGISTS, RESEARCHERS, GENETICISTS, NURSES, COLORECTAL CANCER REGISTRY COORDINATORS, GENETIC COUNSELORS, PSYCHOLOGISTS AND OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE CARE OF INDIVIDUALS WITH HEREDITARY GASTROINTESTINAL CANCERS, INCLUDING COLORECTAL, ESOPHAGEAL, PANCREATIC, GASTRIC AND SMALL BOWEL CANCERS. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS DEVOTED TO THE PURSUIT OF PROVIDING CUTTING EDGE EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS AND ALLIED HEALTH CARE PROFESSIONALS. THIS IS ACHIEVED PRIMARILY THROUGH CONTINUING MEDICAL EDUCATION AND BY PROVIDING A FORUM FOR THE EXCHANGE OF IDEAS AT THE ANNUAL MEETING. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER AIMS TO ENCOURAGE PROFESSIONAL GROWTH, SIMULATE INTELLECTUAL CURIOSITY, AND IMPROVE PATIENT OUTCOMES BY EXPANDING ACCESS TO UP-TO-DATE INFORMATION OF INTEREST TO PRACTITIONERS AND RESEARCHERS. THE ANNUAL MEETING IS DESIGNED TO KEEP CLINICIANS AND SCIENTISTS UP-TO-DATE ON NEW DEVELOPMENTS IN HEREDITARY GASTROINTESTINAL CANCER RESEARCH, INCLUDING IMPLICATIONS IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PATIENTS WITH THE HEREDITARY GASTROINTESTINAL CANCER SYNDROMES. THE PROGRAM IS DIRECTED TO COLORECTAL SURGEONS, MEDICAL ONCOLOGISTS, GASTROENTEROLOGISTS, RESEARCHERS, GENETICISTS, NURSES, COLORECTAL CANCER REGISTRY COORDINATORS, GENETIC COUNSELORS, PSYCHOLOGISTS AND OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE CARE OF INDIVIDUALS WITH HEREDITARY GASTROINTESTINAL CANCERS, INCLUDING COLORECTAL, ESOPHAGEAL, PANCREATIC, GASTRIC AND SMALL BOWEL CANCERS.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 2014.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.